Should Patients With High-Risk or Transformed Myelodysplastic Syndrome Proceed Directly to Allogeneic Transplant Without Prior Cytoreduction by Remission-Induction Chemotherapy or Hypomethylating Agent Therapy?
- Resource Type
- Review Article
- Source
- In
Clinical Lymphoma Myeloma and Leukemia September 2014 14 Supplement:S42-S45 - Subject
- Language
- ISSN
- 2152-2650